Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Global health initiatives news

Show

From To
A UNAIDS–Lancet Commission on Defeating AIDS—Advancing Global Health

The UNAIDS–Lancet Commission has come together at a moment when the lessons of the AIDS response, including its whole-of-society perspective, can be informative and even transformational for other spheres of global health. The path to ending AIDS as a public health threat by 2030, as set out in this report, should be a major part of the post-2015 development agenda.

Published
25 June 2015
From
The Lancet
US funding for HIV treatment linked with employment gains in sub-Saharan Africa

We found that PEPFAR was associated with a 13 percent increase in employment among males in focus nations compared to non-focus ones. In contrast, no change in employment was observed among females. In addition, we found that increasing PEPFAR per capita funding by $100 was associated with a 9.1-percentage-point average increase in employment among males.

Published
15 June 2015
From
Brookings Institution (blog)
UNITAID brings innovation to the global response to HIV/AIDS, TB and Malaria

At a meeting in Rio de Janeiro, the Executive Board announced it would as a first step focus investments in three areas: improving antiretroviral therapy for adults in low and middle-income countries; enabling the expanded use, or "scale-up", of first pre-exposure prophylaxis (PrEP) as a means of preventing HIV transmission; and the development of better tools to diagnose hepatitis C virus (HCV), in particular for people who are co-infected with HIV/HCV.

Published
08 June 2015
From
UNITAID
Obama’s AIDS Boss Appeals to Apax, Nike for Help to Curb HIV

Deborah Birx wants to wring more from the $6.8 billion the U.S. gives her each year to fight AIDS around the world. Hampered by a stagnant budget, she’s cutting off funding to clinics that fail to find HIV cases and looking to Starbucks Corp. and Nike Inc. for ideas.

Published
03 June 2015
From
Bloomberg
The HIV 'emergency' isn't over, says PEPFAR chief

Ambassador Deborah Birx, U.S. global AIDS coordinator and director of the largest initiative to combat a single disease, talks data, PEPFAR's future and the AIDS emergency we still face in this video interview.

Published
28 May 2015
From
Devex
UNAIDS welcomes further evidence that starting antiretroviral therapy early saves lives

“Every person living with HIV should have immediate access to life-saving antiretroviral therapy,” said Michel Sidibé, Executive Director of UNAIDS. “Delaying access to HIV treatment under any pretext is denying the right to health.”

Published
28 May 2015
From
UNAIDS
ViiV Healthcare and CHAI collaboration delivers second milestone with first filing with the FDA of generic dolutegravir by Aurobindo Pharma for the treatment of HIV

ViiV Healthcare, Aurobindo Pharma, and the Clinton Health Access Initiative, Inc. (CHAI) announced today that Aurobindo Pharma has submitted an Abbreviated New Drug Application (ANDA) for dolutegravir 50mg, for Tentative Approval, to the Food and Drug Administration (FDA), for the treatment of HIV. This is the first ANDA for a generic version of dolutegravir, less than two years after FDA approval of Tivicay® (dolutegravir) for sale in the United States. Upon receiving Tentative Approval from the FDA, Aurobindo Pharma will be able to supply dolutegravir 50mg via the President’s Emergency Plan for AIDS Relief (PEPFAR) programme, following completion of required local regulatory approval process, in the licensed countries outside of the United States, as per the agreement signed between Aurobindo Pharma and ViiV Healthcare in 2014.

Published
26 May 2015
From
ViiV Healthcare
WHO Advances Research and Development Financing Effort; Global R&D Observatory To Launch In January

World Health Organization members in committee this week took note of a report by the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG), which was set up to find ways to fund research on diseases afflicting poor populations which have little market incentive for the private sector. The report included a proposal for a voluntary pooled fund that would focus on the development of effective and affordable health technologies for such neglected diseases.

Published
26 May 2015
From
Intellectual Property Watch
World Health Assembly: Experts discuss delinking drug R&D costs from pricing to make them affordable

The problem of drug prices eating up national health budgetscame up at the annual World Health Assembly, which took place from 18-26 May. Last week, a panel of experts discussed the merits of lowering those prices by delinking research and development costs from pricing.

Published
26 May 2015
From
Intellectual Property Watch
Funders' priorities and targets hindered community mobilisation and meaningful participation of sex workers in India

Two qualitative studies, investigating the implementation of a massive programme of HIV prevention through community mobilisation in India, have identified challenges to the rapid scale-up and roll-out

Published
25 May 2015
By
Roger Pebody
← First12345...67Next →

Filter by country